Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Gross Profit (2021 - 2025)

Historic Gross Profit for Ascendis Pharma A (ASND) over the last 5 years, with Q4 2025 value amounting to $260.7 million.

  • Ascendis Pharma A's Gross Profit rose 5255.41% to $260.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $715.3 million, marking a year-over-year increase of 10767.95%. This contributed to the annual value of $706.6 million for FY2025, which is 10702.53% up from last year.
  • As of Q4 2025, Ascendis Pharma A's Gross Profit stood at $260.7 million, which was up 5255.41% from $223.6 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Gross Profit registered a high of $260.7 million during Q4 2025, and its lowest value of $899852.1 during Q1 2021.
  • In the last 5 years, Ascendis Pharma A's Gross Profit had a median value of $34.3 million in 2023 and averaged $67.3 million.
  • Per our database at Business Quant, Ascendis Pharma A's Gross Profit skyrocketed by 105433.83% in 2022 and then crashed by 2960.24% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Gross Profit (Quarter) stood at $1.6 million in 2021, then soared by 1054.34% to $18.1 million in 2022, then surged by 601.2% to $127.2 million in 2023, then soared by 34.3% to $170.9 million in 2024, then surged by 52.55% to $260.7 million in 2025.
  • Its Gross Profit stands at $260.7 million for Q4 2025, versus $223.6 million for Q3 2025 and $143.3 million for Q2 2025.